Transcranial Magnetic Stimulation System - Indianapolis VAMC

This is a combined synopsis/solicitation (RFQ-36C25026Q1013) issued by the Department of Veterans Affairs, Network Contracting Office 10, for a Transcranial Magnetic Stimulation (TMS) System. The solicitation is a firm-fixed-price, small business set-aside. The required system will be delivered to the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana. The procurement is for one FDA-cleared TMS system to treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). The 14-item requirement includes a base stimulator system, continuously cooled treatment coil, motor threshold determination coil, isolation transformer, cooling unit, patient chair, positioning arm, cart, scalp positioning accessories, stabilization system, and onsite installation and training. Key salient characteristics include non-invasive operation, a flat purchase model with no pay-per-use fees, upgradeable treatment protocols, high patient throughput via liquid cooling, and Theraburst stimulation capability. Quotations are due by September 17, 2026, at 12:00 PM Eastern Time, and must be emailed to Contract Specialist Rachel MacRae. Offers must include a complete technical description, a Unique Entity Identifier (UEI), a completed Buy American Certificate, and a statement accepting the solicitation's terms and conditions. Submissions must also include an authorized distribution letter confirming the contractor is an authorized original equipment manufacturer (OEM) dealer or reseller, as only new, non-gray-market items are accepted. Evaluation will be based on technical capability, price reasonableness, warranty terms, delivery time, and past performance.

This document is the Federal Acquisition Regulation (FAR) 52.225-2 "Buy American Certificate" (OCT 2022) provision, a standard certification required in federal government solicitations to ensure compliance with the Buy American Act. Under this provision, offerors must certify that each proposed end product is a domestic end product, unless specified otherwise. The certification process requires offerors to complete three key steps: 1. Certify that domestic end products listed in the document contain a critical component as defined in the "Buy American-Supplies" clause. 2. Formally list any proposed foreign end products, specifying their country of origin and indicating whether their domestic content exceeds 55% (excluding commercially available off-the-shelf items). 3. Separately list the line item numbers of domestic end products that contain a critical component. The government will evaluate all submitted offers following the policies and procedures outlined in FAR Part 25. To complete the provision, the offeror's authorized representative must sign and date the certificate, providing their printed name, title, and company name and address.